Federal Circuit: PTAB Wrongly Analyzed Prior Art Combination For DNA Patent
WASHINGTON, D.C. — The U.S. Patent Trial and Appeal Board (PTAB) erroneously required a health care company to provide proof for the motivation to combine prior art references “because the prior...To view the full article, register now.
Already a subscriber? Click here to view full article